Author

Omaira Alberquilla

Centre for Biomedical Network Research on Rare DiseasesORCID 0000-0002-0301-8340Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

Rebeca Sánchez‐DomíngueziD· 2 shared Álvaro Martín de BernardoiD· 1 shared Annalisa LattanziiD· 1 shared Carolina RubioiD· 1 shared Cristian Suárez-CabreraiD· 1 shared Daniel Castellano· 1 shared Daniel P. DeveriD· 1 shared Esther Montesinos· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Rebeca Sánchez‐DomínguezORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CD44v6 Drives Tumor Aggressiveness and Chemoresistance in Bladder Cancer

Iris Lodewijk, Carolina Rubio, Pontus Eriksson, Ignacio A. Reina, Esther Montesinos, Miguel Alonso-Sánchez, Laura García-Gómez, Álvaro Martín de Bernardo, Lucía Morales, Cristian Suárez-Cabrera, Omaira Alberquilla, Rebeca Sánchez‐Domínguez, Félix Guerrero‐Ramos, Rosa García-Martin, Lucía Parrilla, , Marta Dueñas

This study identifies CD44v6 as a driver of bladder cancer aggressiveness and chemoresistance, linking its expression to poor patient outcomes and therapeutic resistance.

bioRxiv · Aug 27, 2025 · PreprintCancer Biology

Clinically Relevant Gene Editing in Hematopoietic Stem Cells for the Treatment of Pyruvate Kinase Deficiency Hemolytic Anemia

Sara Fañanas-Baquero, Oscar Quintana Bustamante, Daniel P. Dever, Omaira Alberquilla, Rebeca Sánchez‐Domínguez, Joab Camarena, Isabel Ojeda-Pérez, Mercedes Dessy-Rodríguez, Rolf Turk, Mollie S. Schubert, Annalisa Lattanzi, Liwen Xu, José Luis López Lorenzo, Paola Ilaria Bianchi, Juan Antonio Bueren, , Jose Carlos Segovia

This study uses gene editing in hematopoietic stem cells to treat Pyruvate Kinase Deficiency Hemolytic Anemia, restoring RPK function and ATP levels in erythroid cells.

Molecular Therapy — Methods & Clinical Development · May 13, 2021Peer-reviewedGenetics